NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
61 hedge funds and large institutions have $41.6M invested in Niagen Bioscience, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-4
Holders Change %
-6.15%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
19
Reduced
17
Closed
7
Calls
$90K
Puts
–
Net Calls
+$90K
Net Calls Change
+$24K
Top Buyers
Top Sellers
1 |
TCM
Tieton Capital Management
Yakima,
Washington
|
-$266K |
2 |
Morgan Stanley
New York
|
-$167K |
3 |
Barclays
London,
United Kingdom
|
-$88.3K |
4 |
LI
Leap Investments
Chicago,
Illinois
|
-$69K |
5 |
UBS Group
Zurich,
Switzerland
|
-$57.1K |